安珐特联合易善复治疗非酒精性脂肪肝31例临床观察

Clinical survey of combined treatment for 31 cases of nonalcoholic fatty liver diseases

目的观察安珐特联合易善复治疗非酒精性脂肪性肝炎的临床疗效。方法选取62例非酒精性脂肪性肝炎患者，随机分为两组。观察组31例，采用安珐特联合易善复治疗；对照组31例，采用易善复治疗。疗程均为3个月。观察两组临床症状、肝功能指标、血脂改善效果。结果治疗组疗效总有效率明显优于对照组（P〈0．01）。治疗组临床症状、ALT、AST、甘油三酯、总胆固醇改善明显，与对照组比较，各指标差异均有统计学意义（P〈0．05）。结论安珐特联合易善复对改善脂肪肝及肝功能有明显效果。

Objective To study the elinieal effects of compound embryonic bovine liver extrae and polyene phosphatidyleholine treatment for nonalcoholic fatty liver diseases. Methods 62 eases of nonalcoholic fatty fiver diseases were selected and divided into two groups randomly： therapeutic group and control group. There were 31 eases in each group. In the 3-month treatment, the combination of compound embryonic bovine liver extrae and polyene phosphatidyleholine were used in the therapeutic group, and polyene phosphatidylchofine only in the control group. The clinical symptoms, ALT, AST, triglyeeride and total cholesterol of both groups were detected after the treatment. Results The total rate of effects in therapeutic group was better than that of control group （ P 〈 0.01 ）, and also there were statistical differences in the recover of clinical symptoms, ALT, AST, triglyeeride and total cholesterol between the two groups （ P 〈 0.05 ）. Conclusions The combined treatment of compound embryonic bovine liver extrae and polyene phosphatidylcholine has an obviously therapeutic effect for nonalcoholic fatty liver diseases.